Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | R170Ifs*14 |
| Impact List | frameshift |
| Protein Effect | loss of function |
| Gene Variant Descriptions | PALB2 R170Ifs*14 indicates a shift in the reading frame starting at amino acid 170 and terminating 14 residues downstream causing a premature truncation of the 1186 amino acid Palb2 protein (UniProt.org). R170Ifs*14 confers a loss of function to the Palb2 protein as demonstrated by decreased recruitment to DNA damage sites, reduced Brca2 binding, and loss of Rad51 activation in cultured cells (PMID: 28158555). |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 R170fs PALB2 R170Ifs*14 |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23636037_23636038delCT |
| cDNA | c.509_510delGA |
| Protein | p.R170Ifs*14 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001407299.1 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| XM_017023672 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_001407297.1 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| XM_017023673 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_001407302.1 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_001407298.1 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_001407300.1 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_024675 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| XM_017023672.2 | chr16:g.23636037_23636038delCT | c.509_510delGA | p.R170Ifs*14 | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|